Neuren Pharmaceuticals Ltd (NEU.AX)

NEU.AX on Australia Stock Exchange

0.10AUD
6 Mar 2015
Change (% chg)

-- (--)
Prev Close
$0.10
Open
$0.11
Day's High
$0.11
Day's Low
$0.10
Volume
4,146,189
Avg. Vol
5,631,143
52-wk High
$0.19
52-wk Low
$0.06

NEU.AX

Chart for NEU.AX

About

Neuren Pharmaceuticals Limited is a New Zealand-based biopharmaceutical company focused on the development of new therapies for brain injury, neurodevelopmental and neurodegenerative disorders. The Company is focusing on increasing the value of its key drug products, NNZ-2566 and NNZ-2591, by extending the therapeutic focus from... (more)

Overall

Beta: 1.55
Market Cap(Mil.): $274.73
Shares Outstanding(Mil.): 1,616.04
Dividend: --
Yield (%): --

Financials

  NEU.AX Industry Sector
P/E (TTM): -- 175.69 40.21
EPS (TTM): -0.01 -- --
ROI: -92.82 -2.61 16.34
ROE: -92.69 -4.39 17.27
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks